Navigation Links
Axela Inc. Retains Investment Bank to Evaluate Strategic Opportunities

TORONTO, Feb. 1, 2013 /PRNewswire/ -- Axela Inc. announced it has appointed AmeriTech Advisors healthcare investment banking team to respond to recent strategic interest from life science industry companies. This involves licensing or sale of rights to certain of the company's recently developed multiplex tests and proprietary platform technologies.

Over the last 2 years Axela has successfully transformed itself from being an engineering based, life-science tools company, into a strategically focused solutions provider, poised to exploit large market opportunities in Cancer, Immunology, Specialty Diagnostic and Life Science markets.  Axela has focused its MDX applications on rapidly growing markets which demand the combination of high numbers of gene and/or protein markers, rapid results and competitive pricing.

Axela's Flow-thru Array® platform addresses the gap that exists between multiplexed nucleic acid PCR and high density DNA/RNA arrays. The Ziplex® platform is more cost effective and unlike existing approaches, can be readily integrated into established laboratory workflows while  measuring 125-150 genes.  Recently, capabilities have been expanded to include fully automated multiplex protein analysis, offering significant advantages over bead or plate based platforms.  Ziplex, which is patented with extensive freedom to operate, can simultaneously measure more than 50 proteins rapidly while consuming only a few microliters of sample.  Performance has been demonstrated in infectious diseases, traumatic brain injury, and allergy testing applications.

Axela has also significantly advanced the company's second generation diffractive optics platform in collaboration with SONY DADC as part of a development program called ClearDx. The result is a cost efficient and very flexible protein multiplexing platform designed to move the delivery of Personalized Medicine closer to the patient. The platform is supported by a large patent estate and is uniquely well positioned to deliver highly informative assays in multiplex format (32+) at the point of use for human and veterinary diagnostics, research or bioproduction monitoring.

Strategic alternatives the Company may pursue could include a merger, partnering or other collaboration agreements, an equity or debt financing, sale of the Company or other strategic transactions.  The Company does not intend to disclose developments with respect to this process until the evaluation of strategic alternatives has been completed and the board of directors has approved a specific transaction.

About AmeriTech Advisors
AmeriTech is an investment bank dedicated to providing capital raising and strategic advisory services to emerging growth companies in the technology and medtech sectors with market capitalizations of between $25 million and $500 million. Their bankers have 20 years' experience at major global investment banks and as senior managers at public companies with experience executing successful transactions. Their goal is to build mutually beneficial relationships between our emerging growth company clients, technology and medtech/pharma partners, and their network of investors.

Dan D'Agostino
Managing Director
AmeriTech Advisors
708 Third Avenue, 5th fl.
New York, NY 10017
T: 212-209-3885
C: 917-596-9870
F: 212-209-7101



SOURCE AmeriTech Advisors
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
2. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
3. Life Technologies to Present at Upcoming Investment Conferences in February
4. New investment aims to establish the UK as a global graphene research hub
5. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
6. City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters
7. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
8. Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives
9. Foundation Venture Capital Group Makes Eighth Start-Up Investment
10. Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York
11. David Lichtenstein: Biotechnology is Rich Area for Investment
Post Your Comments:
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
Breaking Biology News(10 mins):